A critical review of human endotoxin administration as an experimental paradigm of depression

Neuroscience and Biobehavioral Reviews

Volumn 34, Issue 1, 2010, Pages 130-143

  DellaGioia, Nicole ^a   Hannestad, Jonas ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anhedonia; Cognition; Cytokines; Depression; Endotoxin; Fatigue; Inflammation; Interleukin; Tumor necrosis factor

Indexed keywords

ALPHA INTERFERON; CELECOXIB; DOCETAXEL; ENDOTOXIN; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; REBOXETINE; TUMOR NECROSIS FACTOR ALPHA; TYPHOID VACCINE;

ANHEDONIA; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; COGNITIVE DEFECT; CYTOKINE PRODUCTION; DEPRESSION; EXPLORATORY BEHAVIOR; FATIGUE; FOOD INTAKE; FOOD PREFERENCE; GUILT; HEPATITIS C; HOPELESSNESS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MOOD CHANGE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; PSYCHOMOTOR RETARDATION; REM SLEEP; REVIEW; SIDE EFFECT; SLEEP DISORDER; SOCIAL BEHAVIOR; SUICIDAL IDEATION; WEIGHT REDUCTION; WORKING MEMORY;

ANIMALS; BRAIN; DEPRESSION; DEPRESSIVE DISORDER; ENDOTOXINS; HUMANS; INFLAMMATION; MODELS, NEUROLOGICAL;

EID: 70350218960     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2009.07.014     Document Type: Review

References (184)

1. Ahima R.S., and Antwi D.A. Brain regulation of appetite and satiety. Endocrinol. Metab. Clin. North Am. 37 (2008) 811-823
2. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J. Psychiatry Neurosci. 34 (2009) 4-20
3. Anisman H., Kokkinidis L., Borowski T., and Merali Z. Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Res. 779 (1998) 177-187
4. Anisman H., and Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci. Biobehav. Rev. 29 (2005) 525-546
5. Anisman H., Merali Z., and Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog. Neurobiol. 85 (2008) 1-74
6. APA. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR (2000), American Psychiatric Publisher
7. Asarian L., Kopf B.S., Geary N., and Langhans W. Pharmacological, but not genetic, disruptions in 5-HT(2C) receptor function attenuate LPS anorexia in mice. Pharmacol. Biochem. Behav. 86 (2007) 493-498
8. Asnis G.M., and De La Garza II R. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J. Clin. Gastroenterol. 40 (2006) 322-335
9. Aubert A., Vega C., Dantzer R., and Goodall G. Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav. Immun. 9 (1995) 129-148
10. Bahador M., and Cross A.S. From therapy to experimental model: a hundred years of endotoxin administration to human subjects. J. Endotoxin Res. 13 (2007) 251-279
11. Barr A.M., Song C., Sawada K., Young C.E., Honer W.G., and Phillips A.G. Tolerance to the anhedonic effects of lipopolysaccharide is associated with changes in syntaxin immunoreactivity in the nucleus accumbens. Int. J. Neuropsychopharmacol. 6 (2003) 23-34
12. Bassukas I.D., Hyphantis T., Gamvroulia C., Gaitanis G., and Mavreas V. Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity. J. Eur. Acad. Dermatol. Venereol. 22 (2008) 257-258
13. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1920-1925
14. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., and Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 25 (2005) 8000-8009
15. Borowski T., Kokkinidis L., Merali Z., and Anisman H. Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia. Neuroreport 9 (1998) 3797-3802
16. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav. Immun. 21 (2007) 863-871
17. Brebner K., Hayley S., Zacharko R., Merali Z., and Anisman H. Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 22 (2000) 566-580
18. Bremmer M.A., Beekman A.T., Deeg D.J., Penninx B.W., Dik M.G., Hack C.E., et al. Inflammatory markers in late-life depression: results from a population-based study. J. Affect. Disord. (2007)
19. Brydon L., Harrison N.A., Walker C., Steptoe A., and Critchley H.D. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol. Psychiatry 63 (2008) 1022-1029
20. Bucks R.S., Gidron Y., Harris P., Teeling J., Wesnes K.A., and Perry V.H. Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: a prospective study. Brain Behav. Immun. 22 (2008) 399-407
21. Campbell S.J., Deacon R.M., Jiang Y., Ferrari C., Pitossi F.J., and Anthony D.C. Overexpression of IL-1beta by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour. Neurobiol. Dis. (2007)
22. Capuron L., Fornwalt F.B., Knight B.T., Harvey P.D., Ninan P.T., and Miller A.H. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?. J. Affect. Disord. (2009)
23. Capuron L., Pagnoni G., Demetrashvili M.F., Lawson D.H., Fornwalt F.B., Woolwine B., et al. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32 (2007) 2384-2392
24. Cavadini G., Petrzilka S., Kohler P., Jud C., Tobler I., Birchler T., et al. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 12843-12848
25. Ching S., Zhang H., Belevych N., He L., Lai W., Pu X.A., et al. Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J. Neurosci. 27 (2007) 10476-10486
26. Christenfeld R., Lubin B., and Satin M. Concurrent validity of the Depression Adjective Check List in a normal population. Am. J. Psychiatry 135 (1978) 582-584
27. Cipriani A., Furukawa T.A., Salanti G., Geddes J.R., Higgins J.P., Churchill R., et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373 (2009) 746-758
28. Cools R. Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist 14 (2008) 381-395
29. Cuijpers P., and Smit F. Excess mortality in depression: a meta-analysis of community studies. J. Affect. Disord. 72 (2002) 227-236
30. D'Mello C., Le T., and Swain M.G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J. Neurosci. 29 (2009) 2089-2102
31. Dauphinee S.M., and Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 86 (2006) 9-22
32. Davis M.C., Zautra A.J., Younger J., Motivala S.J., Attrep J., and Irwin M.R. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav. Immun. 22 (2008) 24-32
33. de Araujo I.E., Oliveira-Maia A.J., Sotnikova T.D., Gainetdinov R.R., Caron M.G., Nicolelis M.A., et al. Food reward in the absence of taste receptor signaling. Neuron 57 (2008) 930-941
34. De La Garza II R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neurosci. Biobehav. Rev. 29 (2005) 761-770
35. De La Garza II R., Asnis G.M., Fabrizio K.R., and Pedrosa E. Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats. Psychopharmacology (Berl) 179 (2005) 356-365
36. De La Garza II R., Asnis G.M., Pedrosa E., Stearns C., Migdal A.L., Reinus J.F., et al. Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 781-792
37. Dhillo W.S. Appetite regulation: an overview. Thyroid 17 (2007) 433-445
38. Dickerson S.S., Kemeny M.E., Aziz N., Kim K.H., and Fahey J.L. Immunological effects of induced shame and guilt. Psychosom. Med. 66 (2004) 124-131
39. Dinan T., Siggins L., Scully P., O'Brien S., Ross P., and Stanton C. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. J. Psychiatr. Res. 43 (2009) 471-476
40. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27 (2009) 519-550
41. Dome P., Teleki Z., Rihmer Z., Peter L., Dobos J., Kenessey I., et al. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol. Psychiatry 14 (2009) 523-531
42. Dunn A.J., Swiergiel A.H., and de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci. Biobehav. Rev. 29 (2005) 891-909
43. Dunn A.J., Swiergiel A.H., Zhang H., and Quan N. Reduced ingestion of sweetened milk induced by interleukin-1 and lipopolysaccharide is associated with induction of cyclooxygenase-2 in brain endothelia. Neuroimmunomodulation 13 (2006) 96-104
44. Eisenberger N.I., Inagaki T.K., Rameson L.T., Mashal N.M., and Irwin M.R. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage (2009)
45. Elander L., Engstrom L., Hallbeck M., and Blomqvist A. IL-1beta and LPS induce anorexia by distinct mechanisms differentially dependent on microsomal prostaglandin E synthase-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 (2007) R258-R267
46. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem. Int. (2007)
47. Fahey B., Hickey B., Kelleher D., O'Dwyer A.M., and O'Mara S.M. The widely used anti-viral drug interferon-alpha induces depressive- and anxiogenic-like effects in healthy rats. Behav. Brain Res. 182 (2007) 80-87
48. Feldman S.R., Gordon K.B., Bala M., Evans R., Li S., Dooley L.T., et al. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial. Br. J. Dermatol. 152 (2005) 954-960
49. Fitzgerald P., O'Brien S.M., Scully P., Rijkers K., Scott L.V., and Dinan T.G. Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol. Med. 36 (2006) 37-43
50. Fontana R.J., Bieliauskas L.A., Lindsay K.L., Back-Madruga C., Wright E.C., Snow K.K., et al. Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 45 (2007) 1154-1163
51. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32 (2007) 516-531
52. Gaestel M., Kotlyarov A., and Kracht M. Targeting innate immunity protein kinase signalling in inflammation. Nat. Rev. Drug Discov. 8 (2009) 480-499
53. Gelenberg A.J., Thase M.E., Meyer R.E., Goodwin F.K., Katz M.M., Kraemer H.C., et al. The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. J. Clin. Psychiatry 69 (2008) 1513-1528
54. Gerashchenko D., and Shiromani P.J. Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep. Brain Res. 1019 (2004) 162-169
55. Gosselin D., and Rivest S. MyD88 signaling in brain endothelial cells is essential for the neuronal activity and glucocorticoid release during systemic inflammation. Mol. Psychiatry 13 (2008) 480-497
56. Greenberg D.B., Gray J.L., Mannix C.M., Eisenthal S., and Carey M. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J. Pain Symptom. Manage. 8 (1993) 196-200
57. Griffin W.S. Perispinal etanercept: potential as an Alzheimer therapeutic. J. Neuroinflammation 5 (2008) 3
58. Gundersen Y., Opstad P.K., Reistad T., Thrane I., and Vaagenes P. Seven days' around the clock exhaustive physical exertion combined with energy depletion and sleep deprivation primes circulating leukocytes. Eur. J. Appl. Physiol. 97 (2006) 151-157
59. Hamer M., Molloy G.J., de Oliveira C., and Demakakos P. Persistent depressive symptomatology and inflammation: to what extent do health behaviours and weight control mediate this relationship?. Brain Behav. Immun. (2009)
60. Harden L.M., du Plessis I., Poole S., and Laburn H.P. Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol. Behav. 89 (2006) 146-155
61. Harden L.M., du Plessis I., Poole S., and Laburn H.P. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav. Immun. 22 (2008) 838-849
62. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., and Critchley H.D. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry (2009)
63. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Dolan R.J., et al. Neural origins of human sickness in interoceptive responses to inflammation. Biol. Psychiatry (2009)
64. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., and Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780 (1998) 294-303
65. Hellstrom I.C., Danik M., Luheshi G.N., and Williams S. Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus 15 (2005) 656-664
66. Hermann D.M., Mullington J., Hinze-Selch D., Schreiber W., Galanos C., and Pollmacher T. Endotoxin-induced changes in sleep and sleepiness during the day. Psychoneuroendocrinology 23 (1998) 427-437
67. Hermann G.E., and Rogers R.C. TNF{alpha}: a trigger of autonomic dysfunction. Neuroscientist (2007)
68. Hestad K.A., Tonseth S., Stoen C.D., Ueland T., and Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J. ECT 19 (2003) 183-188
69. Himmerich H., Fulda S., Linseisen J., Seiler H., Wolfram G., Himmerich S., et al. Depression, comorbidities and the TNF-alpha system. Eur. Psychiatry (2008)
70. Hojman P., Taudorf S., Lundby C., and Pedersen B.K. Erythropoietin augments the cytokine response to acute endotoxin-induced inflammation in humans. Cytokine. 45 (2009) 154-157
71. Howren M.B., Lamkin D.M., and Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71 (2009) 171-186
72. Huang Y., Henry C.J., Dantzer R., Johnson R.W., and Godbout J.P. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol. Aging (2007)
73. Huffman J.C., Smith F.A., Quinn D.K., and Fricchione G.L. Post-MI psychiatric syndromes: six unanswered questions. Harv. Rev. Psychiatry 14 (2006) 305-318
74. Imeri L., Bianchi S., and Opp M.R. Inhibition of caspase-1 in rat brain reduces spontaneous nonrapid eye movement sleep and nonrapid eye movement sleep enhancement induced by lipopolysaccharide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R197-204
75. Imeri L., and Opp M.R. How (and why) the immune system makes us sleep. Nat. Rev. Neurosci. 10 (2009) 199-210
76. Irwin M.R., and Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. (2007)
77. Irwin M.R., Olmstead R., Valladares E.M., Breen E.C., and Ehlers C.L. Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biol. Psychiatry (2009)
78. Jain N.K., Patil C.S., Kulkarni S.K., and Singh A. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine- or lipopolysaccharide-induced cognitive dysfunction in mice. Behav. Brain Res. 133 (2002) 369-376
79. Janicki-Deverts D., Cohen S., Doyle W.J., Turner R.B., and Treanor J.J. Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect. Brain Behav. Immun. 21 (2007) 301-307
80. Jiang Y., Deacon R., Anthony D.C., and Campbell S.J. Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol. Dis. (2008)
81. Kapas L., Hansen M.K., Chang H.Y., and Krueger J.M. Vagotomy attenuates but does not prevent the somnogenic and febrile effects of lipopolysaccharide in rats. Am. J. Physiol. 274 (1998) R406-R411
82. Kenis G., and Maes M. Effects of antidepressants on the production of cytokines. Int. J. Neuropsychopharmacol. 5 (2002) 401-412
83. Kennedy S.H. Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues Clin. Neurosci. 10 (2008) 271-277
84. Kentner A.C., Takeuchi A., James J.S., Miki T., Seino S., Hayley S., et al. The effects of rewarding ventral tegmental area stimulation and environmental enrichment on lipopolysaccharide-induced sickness behavior and cytokine expression in female rats. Brain Res. 1217 (2008) 50-61
85. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62 (2005) 593-602
86. Konsman J.P., Luheshi G.N., Bluthe R.M., and Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals: a functional anatomical analysis. Eur. J. Neurosci. 12 (2000) 4434-4446
87. Korth C., Mullington J., Schreiber W., and Pollmacher T. Influence of endotoxin on daytime sleep in humans. Infect. Immun. 64 (1996) 1110-1115
88. Kraus M.R., Schafer A., Schottker K., Keicher C., Weissbrich B., Hofbauer I., et al. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomized, double-blind, placebo-controlled study. Gut (2007)
89. Krishnan V., and Nestler E.J. The molecular neurobiology of depression. Nature 455 (2008) 894-902
90. Krueger J.M., Kubillus S., Shoham S., and Davenne D. Enhancement of slow-wave sleep by endotoxin and lipid A. Am. J. Physiol. 251 (1986) R591-R597
91. Krueger J.M., and Majde J.A. Cytokines and sleep. Int. Arch. Allergy Immunol. 106 (1995) 97-100
92. Kwant A., and Sakic B. Behavioral effects of infection with interferon-gamma adenovector. Behav. Brain Res. 151 (2004) 73-82
93. Lacosta S., Merali Z., and Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 818 (1999) 291-303
94. Lancel M., Mathias S., Schiffelholz T., Behl C., and Holsboer F. Soluble tumor necrosis factor receptor (p75) does not attenuate the sleep changes induced by lipopolysaccharide in the rat during the dark period. Brain Res. 770 (1997) 184-191
95. Langhans W. Signals generating anorexia during acute illness. Proc. Nutr. Soc. 66 (2007) 321-330
96. Larson S.J., and Dunn A.J. Behavioral effects of cytokines. Brain Behav. Immun. 15 (2001) 371-387
97. Leonard B.E. The immune system, depression and the action of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry 25 (2001) 767-780
98. Levine J., Barak Y., Chengappa K.N., Rapoport A., Rebey M., and Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40 (1999) 171-176
99. Liebman J.M. Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology. Neurosci. Biobehav. Rev. 7 (1983) 45-72
100. Lindqvist D., Janelidze S., Hagell P., Erhardt S., Samuelsson M., Minthon L., et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry (2009)
101. Loftis J.M., Hauser P., Macey T.A., and Lowe J.D. Can rodents be used to model interferon-alpha-induced depressive symptoms?. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1366 1364-5; author reply
102. Loftis J.M., Huckans M., Ruimy S., Hinrichs D.J., and Hauser P. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci. Lett. (2007)
103. Loftis J.M., Wall J.M., Pagel R.L., and Hauser P. Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats. Psychoneuroendocrinology 31 (2006) 1289-1294
104. Lowry S.F. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24 Suppl. 1 (2005) 94-100
105. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34 (1995) 301-309
106. Magder S., Neculcea J., Neculcea V., and Sladek R. Lipopolysaccharide and TNF-alpha produce very similar changes in gene expression in human endothelial cells. J. Vasc. Res. 43 (2006) 447-461
107. McAfoose J., and Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 33 (2009) 355-366
108. Merali Z., Brennan K., Brau P., and Anisman H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for "free chow" and "earned" sucrose intake. Psychopharmacology (Berl) 165 (2003) 413-418
109. Meyers C.A., Albitar M., and Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104 (2005) 788-793
110. Michie H.R., Manogue K.R., Spriggs D.R., Revhaug A., O'Dwyer S., Dinarello C.A., et al. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318 (1988) 1481-1486
111. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110 (2006) 135-370
112. Miller A.H., Ancoli-Israel S., Bower J.E., Capuron L., and Irwin M.R. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J. Clin. Oncol. 26 (2008) 971-982
113. Miller A.H., Maletic V., and Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65 (2009) 732-741
114. Moller K., Strauss G.I., Qvist J., Fonsmark L., Knudsen G.M., Larsen F.S., et al. Cerebral blood flow and oxidative metabolism during human endotoxemia. J. Cereb. Blood Flow Metab. 22 (2002) 1262-1270
115. Monje M.L., Toda H., and Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 (2003) 1760-1765
116. Monk J.P., Phillips G., Waite R., Kuhn J., Schaaf L.J., Otterson G.A., et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J. Clin. Oncol. 24 (2006) 1852-1859
117. Moreau M., Andre C., O'Connor J.C., Dumich S.A., Woods J.A., Kelley K.W., et al. Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain Behav. Immun. (2008)
118. Morrow J.D., and Opp M.R. Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient mice. Brain Behav. Immun. 19 (2005) 40-51
119. Muller N., Schwarz M.J., Dehning S., Douhe A., Cerovecki A., Goldstein-Muller B., et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11 (2006) 680-684
120. Mullington J., Korth C., Hermann D.M., Orth A., Galanos C., Holsboer F., et al. Dose-dependent effects of endotoxin on human sleep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278 (2000) R947-R955
121. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (1997) 1436-1442
122. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N. Engl. J. Med. 344 (2001) 961-966
123. Myint A.M., Leonard B.E., Steinbusch H.W., and Kim Y.K. Th1, Th2, and Th3 cytokine alterations in major depression. J. Affect. Disord. 88 (2005) 167-173
124. Netea M.G., Kullberg B.J., Vonk A.G., Verschueren I., Joosten L.A., and van der Meer J.W. Increased voluntary exercise in mice deficient for tumour necrosis factor-alpha and lymphotoxin-alpha. Eur. J. Clin. Invest. 37 (2007) 737-741
125. Norcross J.C., Guadagnoli E., and Prochaska J.O. Factor structure of the Profile of Mood States (POMS): two partial replications. J. Clin. Psychol. 40 (1984) 1270-1277
126. Nutt D., Wilson S., and Paterson L. Sleep disorders as core symptoms of depression. Dialogues Clin. Neurosci. 10 (2008) 329-336
127. O'Brien S.M., Scully P., Fitzgerald P., Scott L.V., and Dinan T.G. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J. Psychiatr Res. 41 (2007) 326-331
128. Opp M.R., and Toth L.A. Somnogenic and pyrogenic effects of interleukin-1beta and lipopolysaccharide in intact and vagotomized rats. Life Sci. 62 (1998) 923-936
129. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 163 (2006) 1630-1633
130. Papakostas G.I., Nutt D.J., Hallett L.A., Tucker V.L., Krishen A., and Fava M. Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol. Psychiatry 60 (2006) 1350-1355
131. Pavlov V.A., and Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav. Immun. 19 (2005) 493-499
132. Pecchi E., Dallaporta M., Jean A., Thirion S., and Troadec J.D. Prostaglandins and sickness behavior: old story, new insights. Physiol. Behav. (2009)
133. Penninx B.W., Kritchevsky S.B., Yaffe K., Newman A.B., Simonsick E.M., Rubin S., et al. Inflammatory markers and depressed mood in older persons: results from the Health Aging and Body Composition Study. Biol. Psychiatry 54 (2003) 566-572
134. Pisani M.A., Murphy T.E., Van Ness P.H., Araujo K.L., and Inouye S.K. Characteristics associated with delirium in older patients in a medical intensive care unit. Arch. Intern. Med. 167 (2007) 1629-1634
135. Pizzagalli D.A., Holmes A.J., Dillon D.G., Goetz E.L., Birk J.L., Bogdan R., et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am. J. Psychiatry (2009)
136. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55 (2007) 453-462
137. Raison C.L., Borisov A.S., Majer M., Drake D.F., Pagnoni G., Woolwine B.J., et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol. Psychiatry (2008)
138. Reichenberg A., Kraus T., Haack M., Schuld A., Pollmacher T., and Yirmiya R. Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion. Psychoneuroendocrinology 27 (2002) 945-956
139. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58 (2001) 445-452
140. Reyes T.M., and Coe C.L. Interleukin-1 beta differentially affects interleukin-6 and soluble interleukin-6 receptor in the blood and central nervous system of the monkey. J. Neuroimmunol. 66 (1996) 135-141
141. Riemann D. Insomnia and comorbid psychiatric disorders. Sleep Med. 8 Suppl. 4 (2007) S15-20
142. Rossi-George A., Urbach D., Colas D., Goldfarb Y., and Kusnecov A.W. Neuronal, endocrine, and anorexic responses to the T-cell superantigen staphylococcal enterotoxin A: dependence on tumor necrosis factor-alpha. J. Neurosci. 25 (2005) 5314-5322
143. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163 (2006) 1905-1917
144. Sammut S., Bethus I., Goodall G., and Muscat R. Antidepressant reversal of interferon-alpha-induced anhedonia. Physiol. Behav. 75 (2002) 765-772
145. Sammut S., Goodall G., and Muscat R. Acute interferon-alpha administration modulates sucrose consumption in the rat. Psychoneuroendocrinology 26 (2001) 261-272
146. Schubert C., Hong S., Natarajan L., Mills P.J., and Dimsdale J.E. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav. Immun. 21 (2007) 413-427
147. Semmler A., Frisch C., Debeir T., Ramanathan M., Okulla T., Klockgether T., et al. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp. Neurol. 204 (2007) 733-740
148. Shoham S., Davenne D., Cady A.B., Dinarello C.A., and Krueger JM. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am. J. Physiol. 253 (1987) R142-R149
149. Simons C.J., Jacobs N., Derom C., Thiery E., Jolles J., van Os J., et al. Cognition as predictor of current and follow-up depressive symptoms in the general population. Acta Psychiatr. Scand. (2009)
150. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., and Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. N. Y. Acad. Sci. 762 (1995) 474-476
151. Sparkman N.L., Buchanan J.B., Heyen J.R., Chen J., Beverly J.L., and Johnson RW. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J. Neurosci. 26 (2006) 10709-10716
152. Spath-Schwalbe E., Hansen K., Schmidt F., Schrezenmeier H., Marshall L., Burger K., et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocrinol. Metab. 83 (1998) 1573-1579
153. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 42 (2008) 151-157
154. Stone E.A., Lehmann M.L., Lin Y., and Quartermain D. Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior. Biol. Psychiatry 60 (2006) 803-811
155. Strike P.C., Wardle J., and Steptoe A. Mild acute inflammatory stimulation induces transient negative mood. J. Psychosom. Res. 57 (2004) 189-194
156. Suffredini A.F., Hochstein H.D., and McMahon FG. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J Infect Dis 179 (1999) 1278-1282
157. Sutcigil L., Oktenli C., Musabak U., Bozkurt A., Cansever A., Uzun O., et al. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin. Dev. Immunol. 2007 (2007) 76396
158. Swiergiel A.H., and Dunn A.J. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol. Biochem. Behav. 86 (2007) 651-659
159. Taylor J.L., and Grossberg S.E. The effects of interferon-alpha on the production and action of other cytokines. Semin. Oncol. 25 (1998) 23-29
160. Taudorf S., Krabbe K.S., Berg R.M., Pedersen B.K., and Moller K. Human models of low-grade inflammation: bolus versus continuous infusion of endotoxin. Clin. Vaccine Immunol. 14 (2007) 250-255
161. Taylor M.J., Freemantle N., Geddes J.R., and Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch. Gen. Psychiatry 63 (2006) 1217-1223
162. Tonelli L.H., Stiller J., Rujescu D., Giegling I., Schneider B., Maurer K., et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr. Scand. 117 (2008) 198-206
163. Trachsel L., Schreiber W., Holsboer F., and Pollmacher T. Endotoxin enhances EEG alpha and beta power in human sleep. Sleep 17 (1994) 132-139
164. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163 (2006) 28-40
165. Tuglu C., Kara S.H., Caliyurt O., Vardar E., and Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170 (2003) 429-433
166. Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367 (2006) 29-35
167. van der Poll T., Coyle S.M., Levi M., Jansen P.M., Dentener M., Barbosa K., et al. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 89 (1997) 3727-3734
168. van Eijk L.T., Dorresteijn M.J., Smits P., van der Hoeven J.G., Netea M.G., and Pickkers P. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit. Care Med. 35 (2007) 1464-1469
169. Vedder H., Schreiber W., Schuld A., Kainz M., Lauer C.J., Krieg J.C., et al. Immune-endocrine host response to endotoxin in major depression. J. Psychiatr. Res. 41 (2007) 280-289
170. Warren E.J., Finck B.N., Arkins S., Kelley K.W., Scamurra R.W., Murtaugh M.P., et al. Coincidental changes in behavior and plasma cortisol in unrestrained pigs after intracerebroventricular injection of tumor necrosis factor-alpha. Endocrinology 138 (1997) 2365-2371
171. Weil Z.M., Bowers S.L., Pyter L.M., and Nelson R.J. Social interactions alter proinflammatory cytokine gene expression and behavior following endotoxin administration. Brain Behav. Immun. 20 (2006) 72-79
172. Weiland T.J., Anthony-Harvey-Beavis D., Voudouris N.J., and Kent S. Metabotropic glutamate receptors mediate lipopolysaccharide-induced fever and sickness behavior. Brain Behav. Immun. 20 (2006) 233-245
173. Wichers M.C., Kenis G., Koek G.H., Robaeys G., Nicolson N.A., and Maes M. Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J. Psychosom. Res. 62 (2007) 207-214
174. Williams K., and Reynolds M.F. Sexual dysfunction in major depression. CNS Spectr. 11 (2006) 19-23
175. Wisse B.E., Ogimoto K., Tang J., Harris Jr. M.K., Raines E.W., and Schwartz M.W. Evidence that lipopolysaccharide-induced anorexia depends upon central, rather than peripheral, inflammatory signals. Endocrinology 148 (2007) 5230-5237
176. Wolff S., Klatt S., Wolff J.C., Wilhelm J., Fink L., Kaps M., et al. Endotoxin-induced gene expression differences in the brain and effects of iNOS inhibition and norepinephrine. Intensive Care Med. 35 (2009) 730-739
177. Wright C.E., Strike P.C., Brydon L., and Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav. Immun. 19 (2005) 345-350
178. Yang K., Xie G., Zhang Z., Wang C., Li W., Zhou W., et al. Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust. N. Z. J. Psychiatry 41 (2007) 266-273
179. Yilmaz M.S., Millington W.R., and Feleder C. The preoptic anterior hypothalamic area mediates initiation of the hypotensive response induced by LPS in male rats. Shock 29 (2008) 232-237
180. Yirmiya R., Avitsur R., Donchin O., and Cohen E. Interleukin-1 inhibits sexual behavior in female but not in male rats. Brain Behav. Immun. 9 (1995) 220-233
181. Yirmiya R., Pollak Y., Barak O., Avitsur R., Ovadia H., Bette M., et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24 (2001) 531-544
182. Zheng D., Macera C.A., Croft J.B., Giles W.H., Davis D., and Scott W.K. Major depression and all-cause mortality among white adults in the United States. Ann. Epidemiol. 7 (1997) 213-218
183. Zhou H., Lapointe B.M., Clark S.R., Zbytnuik L., and Kubes P. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J. Immunol. 177 (2006) 8103-8110
184. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15 (2001) 199-226